Uses of Meyerflavone

Meyerflavo is an antispasmodic urinary tract drug, made in the form of tablets with the main active ingredient is Flavoxate hydrochloride. The following article provides you with information about the uses and precautions when using Meyerflavo.

Meyerflavo is an antispasmodic of the urinary tract, with the main active ingredient being Flavoxate hydrochloride. Meyerflavo is a film-coated tablet with a strength of 200mg.
Flavoxate hydrochloride is a derivative of Flavone, the drug has a direct effect against smooth muscle spasm, mainly on urinary smooth muscle. Flavoxate hydrochloride is also antispasmodic of smooth muscle in the gallbladder, small intestine, uterus and seminal vesicles. The drug acts as a direct relaxant of smooth muscle by inhibiting phosphodiesterase.
Flavoxate hydrochloride also works to increase bladder capacity in patients with bladder spasticity. Flavoxate hydrochloride is especially effective in treating spasticity of the bladder muscles, increasing urinary capacity. The onset of action is 55 - 60 minutes. Flavoxate hydrochloride has a weak antihistamine, analgesic and anesthetic effect. When using the drug in high doses, the anticholinergic effect is weak.

Meyerflavo drug is indicated in the treatment of the following cases:
Helps relieve symptoms, but does not completely cure: urgent urination, difficulty urinating, nocturia, urinary frequency and urinary frequency in the pathologies of kidney disease. prostate and bladder. Support antispasmodic treatment in diseases such as: Kidney stones; ureteral stones; spasmodic disorders of urinary tract due to urinary catheterization, bladder stones and sequelae of lower urinary tract surgery. Reduces spasms in the female genital tract such as menstrual pain, pelvic pain, hypertonia and uterine motility disorders. Meyerflavo is contraindicated in the following cases:
Allergy or hypersensitivity to Flavoxate hydrochloride or any other ingredient in Meyerflavo. The following obstructive conditions: ileus, pyloric or duodenal obstruction, intestinal obstruction or paralytic lesions, gastrointestinal bleeding, non-dilated smooth muscle, lower urinary tract obstruction.

Meyerflavo is taken orally. In case of stomach irritation, the medicine can be taken with food or milk. Dosage of Meyerflavo is indicated as follows:
Adults and children over 12 years old: 1 tablet 200mg x 3-4 times/day. Flavoxate hydrochloride is rapidly absorbed. The clinical response will vary depending on the patient's condition and general condition. The therapeutic effect on the bladder muscle system usually appears within 2 to 3 hours after taking the drug.
In the case of patients with urinary tract infections, treatment is often combined with appropriate antibacterial therapy.
Patients with chronic bladder symptoms need maintenance therapy to achieve optimal effect. If symptoms improve, dose reduction may be considered.
Meyerflavo overdose and management:
Meyerflavo overdose causes anticholinergic effects with symptoms such as severe dizziness, clumsy movements or unsteadiness; drowsiness, fever; blush; illusion; respiratory disorders; agitation, restlessness or irritability. Treatment: Reduce the absorption of Flavoxate hydrochloride by induction of vomiting or gastric lavage if the drug overdose within 4 hours. Specific treatment is by using drugs belonging to the group of parasympathetic nervous system. In addition, supportive treatment measures should be applied to the patient. What to do when you miss a dose of Meyerflavo:
If you forget to take a dose of Meyerflavo, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and take the next dose as scheduled. Also, do not double the dose of Meyerflavo.

Meyerflavo side effects are rare, including some of the following symptoms: Nausea and vomiting, dry mouth/throat, drowsiness, dizziness, headache, emotional instability, difficulty concentrating, eye accommodation disorder, glaucoma , blurred vision, dilated pupils, increased sensitivity of eyes to light, urticaria or other skin diseases, confusion, urinary disturbances, tachycardia, palpitations chest pain, fever, eosinophilia and may cause constipation or diarrhea.

Meyerflavo should be used with caution in patients with suspected glaucoma, congestive heart failure, tachycardia, coronary artery disease. If dry mouth symptoms persist for more than 2 weeks, consult a doctor. Use with caution in the elderly because Flavoxate hydrochloride has anticholinergic activity (causes confusion, blurred vision, tachycardia, constipation). Safety and effectiveness of Flavoxate hydrochloride have not been established in children under 12 years of age, so it should not be used in children of this age. Flavoxate hydrochloride can cause drowsiness, dizziness and eye disorders. Meyerflavo should be used with caution when driving and operating machinery. Pregnancy: There are no adequate and well-controlled studies of the use of Flavoxate hydrochloride in pregnant women. Avoid administering Meyerflavo to pregnant women unless clearly needed. Lactation: It is not known whether Flavoxate hydrochloride is excreted in human milk. Meyerflavo should be used with caution in this population.

Increased effects or toxicity of Flavoxate hydrochloride: Flavoxate hydrochloride may increase the concentration or effect of anticholinergics, cannabinoids and potassium chloride. Flavoxate hydrochloride concentrations may be increased when used concomitantly with Pramlintide. Flavoxate hydrochloride may decrease the concentration or effect of the acetylcholinesterase inhibitor (central nervous system), secretin. Ethanol: Avoid concomitant use with Flavoxate hydrochloride because it may increase central nervous system depression. Meyerflavo is indicated for the treatment of symptoms of dysuria, urgency, nocturia, urinary frequency and interruption in diseases of the bladder and prostate. In addition, the drug is also effective in treating spasms in diseases such as kidney stones, ureteral stones. Before using Meyerflavo, it is best to consult your doctor for instructions on safe and effective use of the drug.